Blog

Comparing Pregabalin vs. Gabapentin

Gabapentin and pregabalin are similar drugs but differ in several distinct ways. The main differences are their indications—specific uses that the Food and Drug Administration (FDA) has approved them to treat—and their dosages.

Gabapentin and pregabalin are FDA-approved to treat some of the same conditions, including postherpetic neuralgia in adults. Fadogia Agrestis Testosterone

Comparing Pregabalin vs. Gabapentin

Both drugs are also indicated to treat partial seizures in adults and certain children with epilepsy (a seizure disorder) when taken along with other medication. Pregabalin is approved for additional uses, including fibromyalgia and nerve pain in certain adults.

Healthcare providers commonly prescribe these medications for off-label uses (non-FDA-approved uses) as well, such as anxiety disorders.

Note that pregabalin is currently approved for treating generalized anxiety disorder (GAD) in Europe, but not in the United States.

Continue reading for an in-depth comparison of pregabalin versus gabapentin, including an analysis of their respective uses, proven efficacy, dosing regimens, side effects, and more. 

One of the primary differences between gabapentin and pregabalin is that the FDA has approved both drugs for some of the same indications but also different ones.

The chart below shows the indications for which the FDA approves gabapentin and pregabalin to treat:

Healthcare providers may prescribe gabapentin or pregabalin for other uses besides the conditions specified by the FDA.

Examples of off-label uses include:

Gabapentin and pregabalin belong to the same drug class known as anticonvulsants. This drug class is also called antiepileptic drugs (AEDs) or simply seizure medications.

These medications work by mimicking the effects of gamma-aminobutyric acid (GABA).

GABA is thought to have a calming effect and reduces nerve activity in the brain, which is believed to slow down nerve signals involved in seizures and pain.

Even though these drugs belong to the same class, pregabalin is more potent than gabapentin on a per-milligram (mg) basis.

As such, pregabalin comes in lower strength than gabapentin. (See the Administration section below for more details comparing their strengths and dosages.)

Another difference is that gabapentin has been around longer. The FDA initially approved gabapentin in 1993 as the brand Neurontin.

Later, gabapentin also became available in extended-release (ER) formulations, such as Gralise.

The FDA approved pregabalin, sold under the brand name Lyrica, in 2004. An ER version of pregabalin, Lyrica CR, is also available.

This section describes the typical dosing information for pregabalin and gabapentin. Be sure to follow your healthcare provider’s instructions.

The table below compares the forms and strengths available for pregabalin and gabapentin:

The dosing for gabapentin and pregabalin depends on the condition being treated. Your healthcare provider will give you a lower dose when you start treatment with either drug.

From there, they’ll increase the amount until they find the dosage that works for you.

Your healthcare provider may continue giving you a lower dosage in certain special situations or if you have kidney problems.

Below are examples of the typical dosages for pregabalin in adults:

Pregabalin is only approved for one use in children: partial seizures. For this use, pregabalin dosage depends on the child’s body weight.

The drug is used in children ages 1 month and older. It’s typically prescribed in combination with other seizure medications. A healthcare provider can supply information about the pediatric dosage of pregabalin. 

Pregabalin may be prescribed for other uses that are considered off-label.  Conversely, a healthcare provider can give you more details about pregabalin dosage for off-label uses.

Here are some examples of the typical doses for gabapentin in adults:

To treat partial seizures in children, the dosage of gabapentin depends on the child’s body weight. The drug may be prescribed for children ages 3 years and older.

A healthcare provider can provide more details about the pediatric dosage of gabapentin. Other available versions of gabapentin are Gralise and Horizant. These brands come in ER forms that are usually taken once a day. 

Gabapentin is commonly prescribed for other uses that are considered off-label.

Therefore, if needed, your healthcare provider can offer more details about the dosage of gabapentin for these or other off-label uses.

You shouldn’t suddenly stop taking gabapentin or pregabalin.

If you want to control the medication, consult a provider about how to stop it safely, usually by slowly reducing your dose over a couple of weeks before stopping it completely.

Numerous clinical trials have examined whether pregabalin or gabapentin is more effective for treating specific conditions. Some of the trial findings are explained below.

Note, however, that the results of a clinical trial may not indicate how each individual outside of clinical trials will respond to treatment.

Seizure: Some evidence suggests that pregabalin is more effective than gabapentin for treating partial seizures in people with epilepsy.

However, other studies have shown that pregabalin was not any better than gabapentin in reducing the frequency of seizures.

Pregabalin and gabapentin are adjunct treatments for partial seizures, meaning that they must be taken in combination with other antiepileptic drugs (seizure medications). 

Pain: A study found no significant difference in the effectiveness of pregabalin and gabapentin for treating nerve pain after spinal cord injury.

However, another study found gabapentin to be superior to pregabalin for the treatment for chronic sciatica.

Anxiety: In a small clinical trial, gabapentin was shown to be more effective for anxiety, insomnia, and fatigue symptoms in adults with low-back pain. However, the trial found that pregabalin was more effective for pain reduction.

Consult a healthcare provider if your current medication isn’t helping your symptoms. They can determine if a different dose or another drug would be more effective. 

The chart below compares the half-life of gabapentin and pregabalin. It takes about five half-lives (the time it takes for the amount of a drug's active substance in your body to reduce by half) to clear a drug from your system.

The chart also shows how long each drug takes to reach its maximum concentration in your blood:

Gabapentin and pregabalin are available in immediate-release (IR) and ER versions.

In general, ER versions of drugs require less frequent dosing than IR forms.

Brand names of gabapentin include Neurontin,  Gralise, and Horizant.

Horizant is an ER tablet that contains gabapentin enacarbil and is approved to treat restless legs syndrome and postherpetic neuralgia.

The brand name of pregabalin IR is Lyrica; an extended-release version is Lyrica CR.

Examples of common side effects associated with the use of gabapentin and pregabalin include the following:

Rarely, more severe side effects of gabapentin and pregabalin may include:

Gabapentin and pregabalin are not safe for everyone. Before starting gabapentin or pregabalin, talk to a healthcare provider about your health history.

This includes any surgeries, allergic reactions, and any medical conditions you have or have had, as this information helps healthcare providers determine which medications are safe for your situation.

Pregabalin can interact with alcohol as well as other drugs.

Gabapentin can also interact with alcohol as well as other drugs. Examples include:

Gabapentin and pregabalin are similar orally administered drugs but differ in their indications and dosages.

Regarding safety, pregabalin is a controlled substance; gabapentin is not. Both drugs are used to treat certain types of nerve-related pain in adults.

They’re also both used to treat seizures in adults and children.

Talk to a healthcare provider to determine if one of these medications may be right for you.

The storage requirements for pregabalin and gabapentin depend on the form of the drug. Both drugs' oral tablets and capsule documents should be stored at room temperature.

The oral liquid solution of pregabalin can also be kept at room temperature, but the gabapentin oral solution should be refrigerated. Additionally, keep all medications out of the reach of children and pets.

Pregabalin is a Schedule V controlled substance that carries risks of misuse, abuse, or addiction.

Gabapentin is not considered a controlled substance. In a research study comparing the potential for addiction, neither gabapentin nor pregabalin were found to be particularly addictive.

However, the researchers concluded that pregabalin seemed “somewhat more addictive” than gabapentin due to the greater extent of behavioral changes that may indicate dependence on pregabalin use.

The term “painkiller” is often used to describe opioid pain medications such as codeine. Pregabalin and gabapentin are not opioids.

However, they can be used to treat nerve-related pain called neuropathy, and they work in a different way than opioid painkillers.

Baldwin DS, den Boer JA, Lyndon G, Emir B, Schweizer E, Haswell H. Efficacy and safety of pregabalin in generalised anxiety disorder: a critical review of the literature. J Psychopharmacol. 2015;29(10):1047-1060. doi:10.1177/0269881115598411

Peckham AM, Evoy KE, Ochs L, Covvey JR. Gabapentin for off-label use: evidence-based or cause for concern? Subst Abuse. 2018;12:1178221818801311. doi:10.1177/1178221818801311

Greenblatt HK, Greenblatt DJ. Gabapentin and Pregabalin for the Treatment of Anxiety Disorders. Clin Pharmacol Drug Dev. 2018;7(3):228-232. doi:10.1002/cpdd.446

National Institute on Drug Abuse. What are prescription CNS depressants?

DailyMed. Label: Neurontin- gabapentin capsule Neurontin- gabapentin tablet, film coated Neurontin- gabapentin solution.

DailyMed. Label: Gralise- gabapentin tablet, film coated Gralise- gabapentin kit.

Food and Drug Administration. Lyrica CR (pregabalin extended-release tablets) label.

Prescribers' Digital Reference. Neurontin (gabapentin) - drug summary.

Prescribers' Digital Reference. Gralise (gabapentin) - drug summary.

Prescribers' Digital Reference. Gabapentin enacarbil - drug summary.

Prescribers' Digital Reference. Pregabalin - drug summary.

Prescribers' Digital Reference. Gabapentin - drug summary.

Delahoy P, Thompson S, Marschner IC. Pregabalin versus gabapentin in partial epilepsy: a meta-analysis of dose-response relationships. BMC Neurol. 2010;10:104. Published 2010 Nov 1. doi:10.1186/1471-2377-10-104

French J, Glue P, Friedman D, et al. Adjunctive pregabalin vs gabapentin for focal seizures: Interpretation of comparative outcomes. Neurology. 2016;87(12):1242-1249. doi:10.1212/WNL.0000000000003118

Davari M, Amani B, Amani B, Khanijahani A, Akbarzadeh A, Shabestan R. Pregabalin and gabapentin in neuropathic pain management after spinal cord injury: a systematic review and meta-analysis. Korean J Pain. 2020;33(1):3-12. doi:10.3344/kjp.2020.33.1.3 

Robertson K, Marshman LAG, Plummer D, Downs E. Effect of gabapentin vs pregabalin on pain intensity in adults with chronic sciatica: a randomized clinical trial. 2019;76(1):117]. JAMA Neurol. 2019;76(1):28-34. doi:10.1001/jamaneurol.2018.3077

Gammoh O, Al-Smadi A, Shawagfeh MQ, et al. The clinical difference between gabapentin and pregabalin: data from a pilot comparative trial. Rev Recent Clin Trials. 2021;16(3):279-287. doi:10.2174/1574887116666210201110507

Ito S. Pharmacokinetics 101. Paediatr Child Health. 2011;16(9):535-6. doi:10.1093/pch/16.9.535

Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet. 2010;49(10):661-669. doi:10.2165/11536200-000000000-00000

Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations.

Prescribers' Digital Reference. Lyrica CR (pregabalin) - drug summary.

Bonnet U, Scherbaum N. How addictive are gabapentin and pregabalin? A systematic review. Eur Neuropsychopharmacol. 2017;27(12):1185-1215. doi:10.1016/j.euroneuro.2017.08.430

By Patricia Weiser, PharmD Patricia Weiser, PharmD, is a licensed pharmacist and freelance medical writer. She has more than 14 years of professional experience.

Thank you, {{form.email}}, for signing up.

There was an error. Please try again.

Comparing Pregabalin vs. Gabapentin

Etonitazene By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.